Recent enforcement activity coordinated by the European Chemicals Agency (ECHA) highlights ongoing challenges in meeting Poison Centre Notification (PCN) obligations. Under the CLP Regulation, PCN is a requirement intended to ensure that medical professionals can quickly access product information during exposure incidents.
What’s Changed: Enforcement Findings
Of over 1,500 hazardous mixtures placed on the market, it was found that approximately 19% had not been notified to poison centres as required under CLP Annex VIII. Meanwhile, 15% of products inspected did not display a Unique Formula Identifier (UFI) on the label as required. The UFI is a critical link between a product placed on the market and the mixture information submitted to poison centres.
Why This Matters
These regulatory measures are intended to enable rapid identification of chemical composition during emergency response. With approximately one in five hazardous mixtures placed on the market not being adequately notified, this represents a significant impediment to coordinated medical response in the event of an exposure incident.
As Chris Van den Hove, Chair of the enforcement project working group, noted:
“Missing notifications of the necessary information to poison centres undermine the effectiveness of emergency response. Inspectors take these findings very seriously and initiated numerous enforcement actions to bring companies into compliance.”
While this level of non-compliance is concerning in itself, the findings also suggest that approximately 4% of products displayed a Unique Formula Identifier (UFI) despite the associated Poison Centre Notification (PCN) not having been completed. This creates a particularly challenging scenario, as the presence of a UFI may give the impression that the relevant compliance steps have been fulfilled while poison centres may not yet have access to the necessary composition data.
In practice, this means that some products may appear compliant at first glance while a critical regulatory step remains outstanding. For actors across the supply chain, this creates a potential visibility gap when assessing whether the products they manufacture, distribute or trade fully meet regulatory requirements.
Implications for Supply Chain Due Diligence
The findings also highlight an important consideration for organisations operating across complex supply chains. The presence of a UFI on a product label should not automatically be interpreted as confirmation that all Poison Centre Notification obligations have been fulfilled. As a matter of good practice, organisations trading hazardous mixtures may wish to request confirmation from suppliers that the relevant PCN submission has been completed and review supporting regulatory documentation. Strengthening internal verification processes can help ensure that products placed on the market meet regulatory requirements and that poison centres have access to the information necessary to support effective emergency response.
Practical Considerations for Industry
In light of the enforcement findings, organisations placing hazardous mixtures on the EU market may wish to review whether their internal compliance processes adequately address Poison Centre Notification obligations under the CLP Regulation. CLP applies to consumer, industrial and professional-use products and thus the potential compliance impacts are widespread. Key considerations may include:
• confirming that all hazardous mixtures placed on the market have been notified through the Poison Centre Notification (PCN) portal
• ensuring consistency between mixture composition data, Safety Data Sheets and Poison Centre Notifications
• verifying that any Unique Formula Identifier (UFI) appearing on product labels corresponds to a completed Poison Centre Notification
• strengthening internal processes linking formulation data, regulatory submissions and product labelling
• improving supply chain transparency so that distributors and downstream users can verify regulatory compliance status
These considerations relate specifically to the findings of the enforcement project; however, organisations should also ensure that broader regulatory obligations, including those arising under REACH and other applicable product legislation, are addressed.
Deenamic Insight
This review highlights the importance of close alignment between formulation data management, regulatory submissions and product labelling processes, as fragmentation across these functions can lead to gaps in compliance implementation. The possibility that some products carry a UFI while the associated notification remains incomplete illustrates how products may appear compliant while key regulatory steps remain outstanding.
In practice, the same underlying data management and supply chain transparency challenges can also affect compliance under related regulatory frameworks, including REACH and other product legislation.
Future enforcement projects coordinated by ECHA and national authorities will continue to highlight key compliance priorities across the EU chemicals framework. These developments will be explored further in future regulatory updates.
Regulatory Intelligence Updates
Be notified of exclusive regulatory developments, ECHA updates and compliance insights as they emerge.
Early access to the Deenamic regulatory platform will be offered to subscribers.